New Approaches to Modeling Bipolar Disorder
The DOI matches its Crossref record.
Abstract
Modeling in animals is an invaluable tool in exploring the pathophysiology of human diseases and developing better therapies. Models can be generated using a variety of pharmacological, behavioral, and genetic approaches, but they all require extensive subsequent validation. Ideally, validation should be based on three axes: face validity (commonalities between the behavioral features of the model and the human disorder being modeled), predictive validity (the specificity and degree to which drugs effective in humans have a corresponding effect in the model), and construct validity (a possible common mechanistic theory that can explain both the model and the human disorder being modeled). Most existing models for psychiatric disorders were developed from a face validity starting point, wherein a researcher noticed the appearance of a rodent behavior similar to a human pathological behavior and subsequently undertook investigations of predictive and construct validity. Some representative models developed in this manner include the hyperactivity (spontaneous or pharmacologically induced), sensitization, and sleep-deprivation models. In this review, we critically appraise the existing animal models for bipolar disorder, emphasizing their strengths and limitations. Furthermore, we discuss the technological advances that have led to an increased awareness of the roles of signal transduction pathways and neurotrophic cascades in the pathophysiology and treatment of bipolar disorder. New construct validity–driven models focusing on signaling pathways include models based on perturbations of G proteins, phosphoinositide signaling, and mitogen-activated protein (MAP) kinase cascades. These new models hold much promise in delineating the underlying pathophysiology of bipolar disorder and in the development of novel, improved therapeutics. Psychopharmacology Bulletin. 2003;37(1):47-63.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
Psychiatric endophenotypes and the development of valid animal models
Gould, T. D., & Gottesman, I. I. (2006) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00186.x · Cited by 512
Toward constructing an endophenotype strategy for bipolar disorders
Hasler, G., Drevets, W. C., Gould, T. D., Gottesman, I. I., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.006 · Cited by 423
Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 375
Gould, T. D., Quiroz, J. A., Singh, J., Zarate, C. A., & Manji, H. K. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001518 · Cited by 238
Toward developmental models of psychiatric disorders in zebrafish
Norton, W. H. J. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00079 · Cited by 127
Knockout mice in understanding the mechanism of action of lithium
Agam, G., Bersudsky, Y., Berry, G. T., Moechars, D., Lavi-Avnon, Y., & Belmaker, R. H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371121 · Cited by 50
Self-citation
Metadata
- Authors
- Einat, H., PhD, Belmaker, R. H., MD, Manji, A. H. K., & MD
- Venue
- Psychopharmacology Bulletin
- Publisher
- Medworks Media Inc.
- Published
- 2025-08-12
- Volume
- 37
- Issue
- 1
- Pages
- 47-63
- ISSN
- 0048-5764 (ISSN-L)
- 2472-2448
- OpenAlex
- W2419144483
- Cited by
- 60
- References
- 0
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.